Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 6OTHER 5NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Central Nervous System Neoplasms 38Head and Neck Neoplasms 32Lung Neoplasms 31Squamous Cell Carcinoma of Head and Neck 28Lymphoma 27Carcinoma, Non-Small-Cell Lung 23Prostatic Neoplasms 21Breast Neoplasms 18Brain Neoplasms 18Leukemia 15Glioblastoma 15Sarcoma 13Gliosarcoma 13Uterine Cervical Neoplasms 12Astrocytoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Adenocarcinoma of Lung 11Burkitt Lymphoma 10Rhabdomyosarcoma 9Neoplasm Metastasis 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Rectal Neoplasms 8Radiation Injuries 8Oligodendroglioma 8Esophageal Neoplasms 8Colorectal Neoplasms 8Adenocarcinoma Of Esophagus 8Urinary Bladder Neoplasms 6Stomach Neoplasms 6

Interventions

Amifostine 4Cisplatin 3Radiotherapy 2Paclitaxel 2Filgrastim 2Carboplatin 2Peripheral Blood Stem Cell Transplantation 1Octreotide 1Melphalan 1Furosemide 1Etoposide 1Erythropoietin 1Epoetin Alfa 1Duloxetine Hydrochloride 1Brachytherapy 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Radiotherapy × Clear all
NCT00003313 2014-11-21

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
243 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00025298 2012-09-24

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
5 enrolled
Head & Neck

Head and Neck Neoplasms, Nasopharyngeal Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡